• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

TFCP2L1 Blocking Peptide

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3225690

This is a synthetic peptide designed for use in combination with anti-TFCP2L1 antibody madeTarget Description: TFCP2L1 is a candidate CP2 family member. It is expressed in a developmentally regulated fashion in vivo and acts as a direct repressor of… More details

$195 / 0.1 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
TFCP2L1, Blocking Peptide
Full Product Name
TFCP2L1 Peptide
Product Gene Name
TFCP2L1 blocking peptide
Product Synonym Gene Name
CRTR1; LBP-9; LBP9
Form/Format
Lyophilized powder
Preparation and Storage
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20 degree C. Avoid repeat freeze-thaw cycles.
Antibody/Peptide Pairs
TFCP2L1 peptide (MBS3225690) is used for blocking the activity of TFCP2L1 antibody (MBS3200643)
Molecular Weight
54kDa
OMIM
609785

Product Categories/Family for TFCP2L1 blocking peptide

Peptide
Applications Tested/Suitable for TFCP2L1 blocking peptide
Immunohistochemistry (IHC), Western Blot (WB)

Other Notes

Small volumes of TFCP2L1 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for TFCP2L1 purchase

MBS3225690 is a blocking peptide targeting TFCP2L1. Also known as TFCP2L1 Peptide.

Additional Details

NCBI/Uniprot data below describe general gene information for TFCP2L1. It may not necessarily be applicable to this product.

NCBI GI #
7657299
NCBI GeneID
29842
NCBI Accession #
NP_055368
UniProt Primary Accession #
Q9NZI6
UniProt Related Accession #
Q9NZI6
GenBank Nucleotide #
NM_014553
NCBI Official Full Name
transcription factor CP2-like protein 1
NCBI Official Synonym Full Names
transcription factor CP2 like 1
NCBI Official Symbol
TFCP2L1
NCBI Official Synonym Symbols
LBP9; CRTR1; LBP-9
UniProt Protein Name
Transcription factor CP2-like protein 1
UniProt Synonym Protein Names
CP2-related transcriptional repressor 1; CRTR-1; Transcription factor LBP-9
Protein Family
Transcription factor CP2-like protein
UniProt Gene Name
TFCP2L1
UniProt Synonym Gene Names
CRTR1; LBP9; CRTR-1
UniProt Entry Name
TF2L1_HUMAN
NCBI Protein Information
transcription factor CP2-like protein 1

UniProt Comments for TFCP2L1

TFCP2L1: Transcriptional suppressor. May suppress UBP1-mediated transcriptional activation. Required for normal duct development in the salivary gland and kidney. Modulates the placental expression of CYP11A1. Belongs to the grh/CP2 family. CP2 subfamily.

Protein type: DNA-binding

Chromosomal Location of Human Ortholog: 2q14

Cellular Component: membrane; cytoplasm; nucleus

Molecular Function: sequence-specific DNA binding; transcription corepressor activity; transcription factor activity

Biological Process: regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; salivary gland development; epithelial cell maturation; cell morphogenesis; cytoplasm organization and biogenesis; female pregnancy; determination of adult life span; negative regulation of transcription from RNA polymerase II promoter; steroid biosynthetic process; positive regulation of growth
Show more

Research Articles on TFCP2L1

1. Study show that CRTR-1 is generally an activator of transcription and that it modulates the activity of other family members, CP2, NF2d9 and altNF2d9, in a cell specific manner.

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with TFCP2L1 blocking peptide

 Reference Product  PubMed Publications
 UBP1 blocking peptide  >4 publications with TFCP2L1 and UBP1

Diseases associated with TFCP2L1 blocking peptide

 Disease Name  Pubmed Publications
 Breast Neoplasms Antibodies  >2 publications with TFCP2L1 and Breast Neoplasms
 Mammary Neoplasms, Animal Antibodies  >1 publications with TFCP2L1 and Mammary Neoplasms, Animal
 Disease Models, Animal Antibodies  >1 publications with TFCP2L1 and Disease Models, Animal
 Kidney Diseases Antibodies  >1 publications with TFCP2L1 and Kidney Diseases
 Adenocarcinoma Antibodies  >1 publications with TFCP2L1 and Adenocarcinoma

Organs/Tissues associated with TFCP2L1 blocking peptide

 Organ/Tissue Name  Pubmed Publications
 Kidney Antibodies  >5 publications with TFCP2L1 and Kidney
 Placenta Antibodies  >3 publications with TFCP2L1 and Placenta
 Thyroid Antibodies  >2 publications with TFCP2L1 and Thyroid
 Bone Antibodies  >1 publications with TFCP2L1 and Bone
 Nerve Antibodies  >1 publications with TFCP2L1 and Nerve
 Lung Antibodies  >1 publications with TFCP2L1 and Lung
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000